Form 8-K - Current report:
SEC Accession No. 0001193125-23-068511
Filing Date
2023-03-13
Accepted
2023-03-13 08:01:29
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d456798d8k.htm   iXBRL 8-K 24565
  Complete submission text file 0001193125-23-068511.txt   142838

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alxo-20230310.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20230310_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20230310_pre.xml EX-101.PRE 10821
6 EXTRACTED XBRL INSTANCE DOCUMENT d456798d8k_htm.xml XML 3290
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 23725772
SIC: 2834 Pharmaceutical Preparations